COX-2 and its prostanoids are involved in several human diseases as various human cancer [61,62] and numerous studies directed to highlight the mechanisms of regulation of its activity, have led to the development of several anti-inflammatory drugs and selective inhibitors that act through a direct inhibition of the enzyme. The gene discussed is PTGS2; the disease is cancer.